Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms.

Bermejo, J; Corral, J; Gentile, J; Lovesio, C; Rodriguez, C; Starosiliz, D; Teglia, O; Curcio, D; Oliva, Me; Whitby, M; Clezy, K; Gordon, D; Dyer, J; Turner, R; Eisen, Pg; Flexman, J; Demeyer, I; Grimard, D; Dubé, F; Gerson, M; Weiss, K; Embil, J; Poirier, A; Bavestrello, L; Northland, R; Fiolic, Z; Marasovic, D; Skerk, V; Cambazard, F; Crickx, B; Kujath, P; Ridwelski, K; Raz, R; Rahav, G; Chowers, M; Zeltser, D; Bassetti, M; Carosi, Giampiero; Cho, Yk; Kim, W; Chung, Dr; Choi, Jy; Lee, S; Rimdeika, R; Halim, As; Seas, C; Checinski, P; Feliga, M; Kaszuba, A; Kolomecki, K; Kruk, M; Silny, W; Wallner, G; Gostichev, V; Laberko, L; Rodoman, G; Shulutko, A; Dekhnich, A; Becker, J; Breedt, J; Perry, J; Ross, D; Cobo, J; Mensa Pueyo, J; Salmeron, L; Chuang, Yc; Chen, Ys; Ho, Jc; Jones, G; Nelson, M; Burnand, K; Alpert, M; Baird, I; Benz, A; Bernstein, J; Beuerlein, J; Borges, R; Boyd, L; Brown, R; Bunce, C; Bush, L; Casey, K; Cairns, B; Clark, C; Dunbar, L; Fetchick, R; Gezon, J; Graham, D; Harkless, L; Harvey, R; Hekmat, R; Holmes, A; Itani, K; Klein, S; Labrada, H; Lamerson, C; Lebuhn, C; Lentnek, A; Levine, D; Mazuski, J; Moursi, M; Niezgoda, J; Nix, L; Nixon, B; O'Riordan, W; Olivencia Yurvati, A; Panacek, E; Penn, R; Pien, F; Pollak, R; Pullman, J; Schrock, C; Schwartz, L; Standiford, H; Stienecker, Rs; Surber, J; Toney, J; Towfigh, S; Tural, A; Weinstock, M; Wilson, S; Wong, G; Yeldandi, V; Young, D.